Justine Telliez
Stock Analyst at Kepler Capital
(4.93)
# 176
Out of 4,334 analysts
354
Total ratings
56.6%
Success rate
56.1%
Average return
Main Sectors:
Stocks Rated by Justine Telliez
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: DBV DBV Technologies S.A. | Maintained: Buy | $5.5 | $3.33 | +65.17% | 26 | May 4, 2026 | |
| EPA: GBT Guerbet SA | Maintained: Hold | $14 | $10.58 | +30.43% | 24 | Apr 24, 2026 | |
| BIT: PHIL Philogen S.p.A. | Maintained: Buy | $34 | $23.40 | +45.30% | 1 | Apr 24, 2026 | |
| SWX: GALD Galderma Group AG | Maintained: Buy | $167 | $158.65 | +5.26% | 12 | Apr 23, 2026 | |
| EPA: ADOC Adocia SA | Maintained: Buy | $12 | $4.97 | +141.25% | 26 | Apr 22, 2026 | |
| EPA: IPN Ipsen S.A. | Maintained: Hold | $132 | $162.70 | -18.87% | 35 | Apr 22, 2026 | |
| EPA: ABVX ABIVAX Société Anonyme | Maintained: Buy | $130 | $115.10 | +12.95% | 33 | Apr 13, 2026 | |
| EPA: SIGHT GenSight Biologics S.A. | Maintained: Hold | $0.4 | $0.0885 | +351.98% | 31 | Apr 8, 2026 | |
| EPA: GNFT Genfit S.A. | Maintained: Buy | $15 | $8.66 | +73.21% | 42 | Apr 7, 2026 | |
| SWX: IDIA Idorsia Ltd | Maintained: Buy | $4.5 | $4.13 | +8.91% | 36 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7.7 → $5.6 | $2.61 | +114.64% | 63 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.1 | $1.61 | n/a | 24 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $3.17 | n/a | 1 | Dec 1, 2023 |
DBV Technologies S.A.
May 4, 2026
Maintained: Buy
Price Target: $5.5
Current: $3.33
Upside: +65.17%
Guerbet SA
Apr 24, 2026
Maintained: Hold
Price Target: $14
Current: $10.58
Upside: +30.43%
Philogen S.p.A.
Apr 24, 2026
Maintained: Buy
Price Target: $34
Current: $23.40
Upside: +45.30%
Galderma Group AG
Apr 23, 2026
Maintained: Buy
Price Target: $167
Current: $158.65
Upside: +5.26%
Adocia SA
Apr 22, 2026
Maintained: Buy
Price Target: $12
Current: $4.97
Upside: +141.25%
Ipsen S.A.
Apr 22, 2026
Maintained: Hold
Price Target: $132
Current: $162.70
Upside: -18.87%
ABIVAX Société Anonyme
Apr 13, 2026
Maintained: Buy
Price Target: $130
Current: $115.10
Upside: +12.95%
GenSight Biologics S.A.
Apr 8, 2026
Maintained: Hold
Price Target: $0.4
Current: $0.0885
Upside: +351.98%
Genfit S.A.
Apr 7, 2026
Maintained: Buy
Price Target: $15
Current: $8.66
Upside: +73.21%
Idorsia Ltd
Mar 30, 2026
Maintained: Buy
Price Target: $4.5
Current: $4.13
Upside: +8.91%
Mar 26, 2026
Maintained: Buy
Price Target: $7.7 → $5.6
Current: $2.61
Upside: +114.64%
May 23, 2025
Maintained: Hold
Price Target: $3.1
Current: $1.61
Upside: n/a
Dec 1, 2023
Maintained: Buy
Price Target: $16
Current: $3.17
Upside: n/a